All Stories

  1. Exploring the Speciation of trans -Aconitic Acid in Aqueous Solution: Interactions with Divalent Metal Cations of Environmental Relevance
  2. Investigation of the metal-binding site 2 of Y. pestis YfeA protein: solution studies of Fe( ii ), Mn( ii ...
  3. The comparison of metal-binding ability of the C-terminal region of Y. pestis, K. pneumoniae, and S. typhimurium FeoB protein
  4. The Coordination Chemistry of Two Peptidic Models of NFeoB and Core CFeoB Regions of FeoB Protein: Complexes of Fe(II), Mn(II), and Zn(II)
  5. Comparative analysis of metal-binding properties of C-terminal FeoB peptide models from selected Gram-negative bacteria
  6. Caffeic Acid Phenethyl Ester: A Potential Therapeutic Cancer Agent?
  7. Interplay of Metal Ions and Posttranslational Modifications in Proteins
  8. An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes
  9. Iron-related Biomarkers in the Diagnosis and Management of Iron Disorders
  10. Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle
  11. Perspectives on Iron Deficiency as a Cause of Human Disease in Global Public Health
  12. Early-Life Lead Exposure: Risks and Neurotoxic Consequences
  13. Berberine: Pharmacological Features in Health, Disease and Aging
  14. Fe(II), Mn(II), and Zn(II) Binding to the C-Terminal Region of FeoB Protein: An Insight into the Coordination Chemistry and Specificity of the Escherichia coli Fe(II) Transporter
  15. A family of kojic acid derivatives aimed to remediation of Pb2+ and Cd2+
  16. Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes
  17. Zn2+ and Cu2+ Interaction with the Recognition Interface of ACE2 for SARS-CoV-2 Spike Protein
  18. Zn<sup>2+</sup> and Cu<sup>2+</sup> Interaction with the Recognition Interface of ACE2 for SARS-CoV-2 Spike Protein
  19. Neurotransmitters Regulation and Food Intake: The Role of Dietary Sources in Neurotransmission
  20. Biological Effects of Human Exposure to Environmental Cadmium
  21. The Role of the Thioredoxin System in Brain Diseases
  22. Coenzyme Q10 in aging and disease
  23. The Role of Astaxanthin as a Nutraceutical in Health and Age-Related Conditions
  24. Natural Compounds and Products from an Anti-Aging Perspective
  25. Combined Supplementation of Coenzyme Q10 and Other Nutrients in Specific Medical Conditions
  26. Selenium: An Antioxidant with a Critical Role in Anti-Aging
  27. Polyphenols in Metabolic Diseases
  28. Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2
  29. Natural Dietary Compounds in the Treatment of Arsenic Toxicity
  30. Structural Identification of Metalloproteomes in Marine Diatoms, an Efficient Algae Model in Toxic Metals Bioremediation
  31. Thioredoxin reductase as a pharmacological target
  32. An updated overview on metal nanoparticles toxicity
  33. Gold nanoparticles and cancer: Detection, diagnosis and therapy
  34. Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach
  35. Metal Toxicity and Speciation: A Review
  36. Gold Clusters: From the Dispute on a Gold Chair to the Golden Future of Nanostructures
  37. Micronutrients deficiences in patients after bariatric surgery
  38. Individual risk management strategy for SARS-CoV-2 infection: A step toward personalized healthcare
  39. Analytical and in silico study of the inclusion complexes between tropane alkaloids atropine and scopolamine with cyclodextrins
  40. Awareness and risk factors of autism spectrum disorder in an Egyptian population
  41. A SARS-CoV-2 –human metalloproteome interaction map
  42. Phosphocalcic metabolism and the role of vitamin D, vitamin K2, and nattokinase supplementation
  43. The microbiota-mediated dietary and nutritional interventions for COVID-19
  44. Rh(I) Complexes in Catalysis: A Five-Year Trend
  45. Iron Deficiency in Obesity and after Bariatric Surgery
  46. Environmental barium: potential exposure and health-hazards
  47. The impact of glutathione metabolism in autism spectrum disorder
  48. The role of B vitamins in stroke prevention
  49. Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis
  50. Interrelations between COVID-19 and other disorders
  51. The Role of Diet and Supplementation of Natural Products in COVID-19 Prevention
  52. The glutathione system in Parkinson’s disease and its progression
  53. A Comprehensive Review on Oxysterols and Related Diseases
  54. The role of glutathione redox imbalance in autism spectrum disorder: A review
  55. Micronutrients as immunomodulatory tools for COVID-19 management
  56. Zinc Interactions with a Soluble Mutated Rat Amylin to Mimic Whole Human Amylin: An Experimental and Simulation Approach to Understand Stoichiometry, Speciation and Coordination of the Metal Complexes
  57. Biomarkers of senescence during aging as possible warnings to use preventive measures
  58. The Proteomics Study of Compounded HFE/TF/TfR2/HJV Genetic Variations in a Thai Family with Iron Overload, Chronic Anemia, and Motor Neuron Disorder
  59. Metals, autoimmunity, and neuroendocrinology: Is there a connection?
  60. Health benefits of xylitol
  61. Arsenic intoxication: general aspects and chelating agents
  62. Mercury-induced autoimmunity: Drifting from micro to macro concerns on autoimmune disorders
  63. Green and efficient configuration of integrated waste heat and cold energy recovery for marine natural gas/diesel dual-fuel engine
  64. Exploring the Specificity of Rationally Designed Peptides Reconstituted from the Cell-Free Extract of Deinococcus radiodurans toward Mn(II) and Cu(II)
  65. Interactions between iron and manganese in neurotoxicity
  66. The essential metals for humans: A brief overview
  67. Medical Uses of Silver: History, Myths, and Scientific Evidence
  68. A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays
  69. New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation
  70. Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+
  71. Mn(II) interaction with proteins responsible for ROS response and defense in DR
  72. Tungsten or Wolfram: Friend or Foe?
  73. The Intriguing Potential of “Minor” Noble Metals: Emerging Trends and New Applications
  74. Noble Metals in Pharmaceuticals: Applications and Limitations
  75. Looking at new ligands for chelation therapy
  76. A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies
  77. para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite
  78. Ni(II) interaction with a peptide model of the human TLR4 ectodomain
  79. Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions
  80. Complex formation equilibria of Cu2+ and Zn2+ with Irbesartan and Losartan
  81. Toxicity of Nanoparticles: Etiology and Mechanisms
  82. Joint 16th International Symposium on Trace Elements in Man and Animals (TEMA-16), 12th Conference of the International Society for Trace Element Research in Humans (ISTERH 2017) and 13th Conference of the Nordic Trace Element Society (NTES 2017)
  83. Chemical features of in use and in progress chelators for iron overload
  84. Silver coordination compounds: A new horizon in medicine
  85. Manganese binding to antioxidant peptides involved in extreme radiation resistance in Deinococcus radiodurans
  86. Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents
  87. Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds
  88. Coordination Environment of Cu(II) Ions Bound to N-Terminal Peptide Fragments of Angiogenin Protein
  89. Substituent effects on ionization constants as a predictive tool of coordinating ability
  90. Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography
  91. Manganism and Parkinson's disease: Mn(ii) and Zn(ii) interaction with a 30-amino acid fragment
  92. Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one
  93. Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators
  94. Tungsten-induced carcinogenesis in human bronchial epithelial cells
  95. An NMR study on the 6,6′-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with AlIII and ZnII ions
  96. Noble metals in medicine: Latest advances
  97. Kill or cure: Misuse of chelation therapy for human diseases
  98. A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity
  99. Nutritional Iron Deficiency: The Role of Oral Iron Supplementation
  100. Toxicity of Nanoparticles
  101. Ni(ii) binding to the 429–460 peptide fragment from human Toll like receptor (hTLR4): a crucial role for nickel-induced contact allergy?
  102. Interaction of Cu(II) and Ni(II) with Ypk9 Protein FragmentviaNMR Studies
  103. The Involvement of Amino Acid Side Chains in Shielding the Nickel Coordination Site: An NMR Study
  104. Nickel binding sites in histone proteins: Spectroscopic and structural characterization
  105. Front cover
  106. Interaction of divalent cations with peptide fragments from Parkinson's disease genes
  107. Manganese and cobalt binding in a multi-histidinic fragment
  108. Mn(ii) and Zn(ii) interactions with peptide fragments from Parkinson's disease genes
  109. NMR studies of zinc binding in a multi-histidinic peptide fragment
  110. Nickel binding to histone H4
  111. Metal-chelating properties of carvedilol: an antihypertensive drug with antioxidant activity
  112. Copper and nickel binding in multi-histidinic peptide fragments
  113. An NMR study on nickel binding sites in Cap43 protein fragments
  114. Copper(ii) binding to Cap43 protein fragments
  115. Paramagnetism-Based NMR Restraints Provide Maximum Allowed Probabilities for the Different Conformations of Partially Independent Protein Domains
  116. 4. Bioinspired Coordination Chemistry
  117. Multidimensional NMR spectroscopy for the study of histone H4–Ni(ii) interaction
  118. Nickel(II) binding to Cap43 protein fragments
  119. Experimentally exploring the conformational space sampled by domain reorientation in calmodulin
  120. The binding of Ni(ii) and Cu(ii) with the N-terminal tail of the histone H4